Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
F 146.44 0.19% 0.28
JNJ closed up 0.19 percent on Monday, July 1, 2024, on 68 percent of normal volume. It ran into resistance at its 50 day moving average.
Earnings due: Jul 17
*** please verify all earnings dates ***
24 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Cup with Handle Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Outside Day Range Expansion 0.00%
20 DMA Resistance Bearish 0.19%
Pocket Pivot Bullish Swing Setup 0.19%
Cup with Handle Other 0.19%
Bollinger Band Squeeze Range Contraction 0.19%
Inside Day Range Contraction 0.19%

   Recent Intraday Alerts

Alert Time
Outside Day about 7 hours ago
Fell Below Previous Day's Low about 7 hours ago
60 Minute Opening Range Breakdown about 8 hours ago
Reversed from Up about 9 hours ago
20 DMA Resistance about 9 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Johnson & Johnson Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Immunology Pain Infectious Diseases Pharmaceutical Products Retail Outlets Dow Jones Component Gastrointestinal Infection Pharmacology Cardiovascular Disease Skin Care Urology Glucose Pain Management Hematology Wound Diagnostic Products Insulin Energy Products Neurology Blood Glucose Monitoring Lenses Contact Lens Contact Lenses General Surgery Infection Prevention Thrombosis Antipsychotic Infection Prevention Products Counter Pharmaceutical Products Insulin Delivery Johnson & Johnson Urological Products

Is JNJ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 170.6187
52 Week Low 141.5705
Average Volume 7,618,784
200-Day Moving Average 152.08
50-Day Moving Average 147.67
20-Day Moving Average 146.75
10-Day Moving Average 146.97
Average True Range 2.08
RSI (14) 46.81
ADX 10.94
+DI 21.92
-DI 20.93
Chandelier Exit (Long, 3 ATRs) 143.47
Chandelier Exit (Short, 3 ATRs) 150.13
Upper Bollinger Bands 148.85
Lower Bollinger Band 144.65
Percent B (%b) 0.43
BandWidth 2.86
MACD Line -0.38
MACD Signal Line -0.43
MACD Histogram 0.0484
Fundamentals Value
Market Cap 352.52 Billion
Num Shares 2.41 Billion
EPS 5.20
Price-to-Earnings (P/E) Ratio 28.16
Price-to-Sales 4.43
Price-to-Book 5.30
PEG Ratio 5.77
Dividend 4.70
Dividend Yield 3.21%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 151.06
Resistance 3 (R3) 151.30 150.00 150.29
Resistance 2 (R2) 150.00 148.82 149.88 150.03
Resistance 1 (R1) 148.22 148.10 149.11 147.98 149.78
Pivot Point 146.92 146.92 147.37 146.80 146.92
Support 1 (S1) 145.14 145.74 146.03 144.90 143.10
Support 2 (S2) 143.84 145.02 143.72 142.85
Support 3 (S3) 142.06 143.84 142.59
Support 4 (S4) 141.82